Science News & Science Current Events
 
Email a Friend Send to a friend
Printer Friendly Print Protein aggregates in Lou Gehrig's disease linked to neuron death

Protein aggregates in Lou Gehrig's disease linked to neuron death

October 27, 2005

EVANSTON, Ill. -- French neurologist Jean-Martin Charcot first described amyotrophic lateral sclerosis (ALS) in 1869, but, nearly 140 years later, little is known about the cause of the devastating neurodegenerative disease, and there is no cure.

What is known about Lou Gehrig's disease, as it is commonly called, is that misfolded and damaged proteins clump together in cells to form aggregates and motor neurons die. But scientists have long debated whether or not the protein aggregates actually kill the cells.




Now a research team at Northwestern University, using mammalian neurons and live-cell time-lapse spectroscopy, has become the first to clearly link the presence of the ALS-associated mutant SOD1 protein aggregates with neuronal cell death. This evidence could help explain the disease process and eventually lead to new therapeutics.

In the study, published this month in the Journal of Cell Biology, the scientists looked one at a time at neuronal cells expressing the mutant SOD1 protein and found that in cells where the protein accumulated and aggregates formed, 90 percent of the cells went on to die. (They died between six and 24 hours after aggregates were visually detected.) Cells that did not form aggregates did not die.

The study also provides a new understanding of the structure and composition of the deadly aggregates - one of the first studies to do so.

"We found that these aggregates are quite peculiar and very different from the aggregates formed in Huntington's disease," said Richard I. Morimoto, Bill A. and Gayle Cook Professor in Biological Sciences, who led the study. Morimoto is an expert in Huntington's disease and on the cellular response to damaged proteins.

"In Huntington's, the aggregate is very dense and impenetrable and binds irreversibly with other molecules in the cell," he said. "In ALS, the aggregates are amorphous, like a sponge. Other proteins can go through the structure and interact with it, which may help explain why mutant SOD1 is so toxic." Morimoto believes this surprising finding indicates that the structure of aggregates associated with other neurodegenerative diseases such as Parkinson's and Alzheimer's will be found to be different as well.

Looking at individual cells in a population, the researchers also found that cells side by side did different things. In cells expressing the same amount of damaged protein, some cells formed aggregates and died and others did not form aggregates and lived. Only a certain subset of at-risk cells went on to lose function and die.

"It would be terrifying if 100 percent of the cells expressing mutant proteins died," said Morimoto. "This means that in many cases the cell's protective machinery suppresses the damaged proteins, keeping the cell healthy. This discovery will be important to scientists looking to develop genetic suppressors and therapeutics."

Morimoto's team focused on SOD1 because it is a form of familial (hereditary) ALS in which a mutation in just one gene and its associated protein has devastating consequences to the cell. (Approximately 10 percent of ALS cases are familial.) This provides experimentalists with a powerful framework. For the other 90 percent the disease is not the result of one mutation but rather a series of many genetic events that debilitate motor neurons. With non-familial forms it is extremely difficult to design hypothesis-based experiments, said Morimoto.

The next question the researchers plan to address is what are the events that lead to cell death once mutant SOD1 protein aggregates form in the cell? This knowledge would help scientists identify small molecules that could halt, arrest or reverse the disease process.

In addition to Morimoto, other authors on the Journal of Cell Biology paper are Carina I. Holmberg, Soojin Kim, Gen Matsumoto (lead author) and Aleksandar Stojanovic, all formerly from Northwestern University.

Northwestern University



Related Lou Gehrigs Disease Current Events and Lou Gehrigs Disease News Articles
Testosterone therapy may prevent Alzheimer's disease
Researchers at the University of Southern California have discovered a direct link between loss of testosterone and the development of an Alzheimer's-like disease in mice. They also discovered that testosterone treatment slows progression of the disease.
More Lou Gehrigs Disease Current Events and Lou Gehrigs Disease News Articles


Als-Lou Gehrig's Disease (Diseases and People)
by Mary Dodson Wade



Walking Through the Valley - Dealing with the Prospects of Death with Bulbar A.L.S. (Lou Gehrig's Disease)
by Howard C. Lund

Every person's journey through life has seasons of challenge and times of great change. But knowing what scripture says about the true reality of our existence provides us with joy, strength and faith to go through the struggle and rise above it. Read how a man with great faith journeys through a seemingly hopeless situation with peace for the day and great hope for the future. It is not an easy...



Diseases and Disorders - Lou Gehrig's Disease (Diseases and Disorders)
by Melissa Abramovitz

Named after baseball superstar Lou Gehrig, this devastating disease paralyzes its victims and leads to death within a few short years in most cases. Causes, treatments, diagnosis, living with the illness, and research are covered....



How To Learn About Lou Gehrig's Disease
by Quick Easy Guides

Lou Gehrig's disease is a common name for the debilitating neurodegenerative disease, amyotrophic lateral sclerosis (ALS). Amyotrophic lateral sclerosis is the disease that forced...Written by experts in the field, Quick Easy Guides share little-known trade secrets and helpful hints to get you moving in the right direction.Quick Easy Guides gives you books you can judge by the cover. Our books...



You've Gotta Fight Back!: Winning with Serious Illness, Injury or Disability
by Dirk, Chase Eldredge

The heart of this book consists of thirteen, riveting, in-depth stories of people who fought back with courage, humor, and a positive attitude. In doing so, they have provided valuable guidance for you, the readers of this inspiring work. The seriously ill, their friends and family will gain priceless advice on coping, dealing with depression, how to partner with the medical profession, the...

Six Parts Love: One Family's Battle With Lou Gehrig's Disease
by Roni Rabin



Falling Practice: What Illness Teaches Us
by Karen Jorgensen

Gale Encyclopedia of Alternative Medicine: Lou Gehrig's disease
by Kathleen Wright

The article is excerpted from Gale Encyclopedia of Alternative Medicine. "Gale's products are known to be thorough, well-researched, and good reference tools. This item is no exception... This is a valuable resource for readers who are seeking information on complementary medicine and herbal remedies. The scope of this encyclopedia is comprehensive, but not definitive. Readers should use ...

Writing for his life. (journalist and Lou Gehrig's Disease victim Brian Dickinson writes columns for the Providence Journal-Bulletin with an eye-activated ... An article from: American Journalism Review
by Florence George Graves

This digital document is an article from American Journalism Review, published by University of Maryland on March 1, 1997. The length of the article is 5790 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.From the...

Terminally sane: One man's journey beyond Lou Gehrig's disease
by Jay A Rouelle

© 2008 BrightSurf.com